{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T01:09:37Z","timestamp":1775351377124,"version":"3.50.1"},"reference-count":163,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,2,9]],"date-time":"2014-02-09T00:00:00Z","timestamp":1391904000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s12015-014-9495-2","type":"journal-article","created":{"date-parts":[[2014,2,8]],"date-time":"2014-02-08T07:31:01Z","timestamp":1391844661000},"page":"351-375","source":"Crossref","is-referenced-by-count":137,"title":["Interferon-Gamma Modification of Mesenchymal Stem Cells: Implications of Autologous and Allogeneic Mesenchymal Stem Cell Therapy in Allotransplantation"],"prefix":"10.1007","volume":"10","author":[{"given":"Kisha Nandini","family":"Sivanathan","sequence":"first","affiliation":[]},{"given":"Stan","family":"Gronthos","sequence":"additional","affiliation":[]},{"given":"Darling","family":"Rojas-Canales","sequence":"additional","affiliation":[]},{"given":"Benjamin","family":"Thierry","sequence":"additional","affiliation":[]},{"given":"P. Toby","family":"Coates","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2014,2,9]]},"reference":[{"key":"9495_CR1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1600-065X.2003.00090.x","volume":"196","author":"PN Rocha","year":"2003","unstructured":"Rocha, P. N., Plumb, T. J., Crowley, S. D., & Coffman, T. M. (2003). Effector mechanisms in transplant rejection. Immunology Reviews, 196, 51\u201364.","journal-title":"Immunology Reviews"},{"issue":"3","key":"9495_CR2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0092-8674(01)00449-4","volume":"106","author":"I Mellman","year":"2001","unstructured":"Mellman, I., & Steinman, R. M. (2001). Dendritic cells: specialized and regulated antigen processing machines. Cell, 106(3), 255\u2013258.","journal-title":"Cell"},{"issue":"1","key":"9495_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jlb.66.1.1","volume":"66","author":"S Sozzani","year":"1999","unstructured":"Sozzani, S., Allavena, P., Vecchi, A., & Mantovani, A. (1999). The role of chemokines in the regulation of dendritic cell trafficking. Journal of Leukocyte Biology, 66(1), 1\u20139.","journal-title":"Journal of Leukocyte Biology"},{"issue":"6970","key":"9495_CR4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nature02238","volume":"427","author":"TR Mempel","year":"2004","unstructured":"Mempel, T. R., Henrickson, S. E., & Von Andrian, U. H. (2004). T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature, 427(6970), 154\u2013159.","journal-title":"Nature"},{"issue":"2\u20133","key":"9495_CR5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0966-3274(02)00055-2","volume":"10","author":"DS Game","year":"2002","unstructured":"Game, D. S., & Lechler, R. I. (2002). Pathways of allorecognition: implications for transplantation tolerance. Transplant Immunology, 10(2\u20133), 101\u2013108.","journal-title":"Transplant Immunology"},{"issue":"25","key":"9495_CR6","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJM199806183382506","volume":"338","author":"MH Sayegh","year":"1998","unstructured":"Sayegh, M. H., & Turka, L. A. (1998). The role of T-cell costimulatory activation pathways in transplant rejection. The New England Journal of Medicine, 338(25), 1813\u20131821.","journal-title":"The New England Journal of Medicine"},{"issue":"4","key":"9495_CR7","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/MOT.0b013e328309ee31","volume":"13","author":"B Afzali","year":"2008","unstructured":"Afzali, B., Lombardi, G., & Lechler, R. I. (2008). Pathways of major histocompatibility complex allorecognition. Current Opinion in Organ Transplantation, 13(4), 438\u2013444.","journal-title":"Current Opinion in Organ Transplantation"},{"issue":"5","key":"9495_CR8","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.4049\/jimmunol.180.5.3081","volume":"180","author":"A Montecalvo","year":"2008","unstructured":"Montecalvo, A., Shufesky, W. J., Stolz, D. B., et al. (2008). Exosomes as a short-range mechanism to spread alloantigen between dendritic cells during T cell allorecognition. Journal of Immunology, 180(5), 3081\u20133090.","journal-title":"Journal of Immunology"},{"key":"9495_CR9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1600-065X.2003.00088.x","volume":"196","author":"DM Rothstein","year":"2003","unstructured":"Rothstein, D. M., & Sayegh, M. H. (2003). T-cell costimulatory pathways in allograft rejection and tolerance. Immunological Reviews, 196, 85\u2013108.","journal-title":"Immunological Reviews"},{"issue":"1","key":"9495_CR10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1600-065X.2009.00781.x","volume":"229","author":"XC Li","year":"2009","unstructured":"Li, X. C., Rothstein, D. M., & Sayegh, M. H. (2009). Costimulatory pathways in transplantation: challenges and new developments. Immunological Reviews, 229(1), 271\u2013293.","journal-title":"Immunological Reviews"},{"issue":"4","key":"9495_CR11","first-page":"293","volume":"46","author":"SA Divate","year":"2000","unstructured":"Divate, S. A. (2000). Acute renal allograft rejection: progress in understanding cellular and molecular mechanisms. Journal of Postgraduate Medicine, 46(4), 293\u2013296.","journal-title":"Journal of Postgraduate Medicine"},{"issue":"1","key":"9495_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.184.1.1","volume":"184","author":"RH Schwartz","year":"1996","unstructured":"Schwartz, R. H. (1996). Models of T cell anergy: is there a common molecular mechanism? The Journal of Experimental Medicine, 184(1), 1\u20138.","journal-title":"The Journal of Experimental Medicine"},{"issue":"1","key":"9495_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/TP.0b013e31823cab44","volume":"93","author":"KJ Wood","year":"2012","unstructured":"Wood, K. J., & Goto, R. (2012). Mechanisms of rejection: current perspectives. Transplantation, 93(1), 1\u201310.","journal-title":"Transplantation"},{"issue":"12","key":"9495_CR14","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1097\/TP.0b013e3181777a39","volume":"85","author":"DM Tarlinton","year":"2008","unstructured":"Tarlinton, D. M., Batista, F., & Smith, K. G. (2008). The B-cell response to protein antigens in immunity and transplantation. Transplantation, 85(12), 1698\u20131704.","journal-title":"Transplantation"},{"issue":"2","key":"9495_CR15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/TP.0b013e3181e25a59","volume":"90","author":"TS Win","year":"2010","unstructured":"Win, T. S., & Pettigrew, G. J. (2010). Humoral autoimmunity and transplant vasculopathy: when allo is not enough. Transplantation, 90(2), 113\u2013120.","journal-title":"Transplantation"},{"key":"9495_CR16","doi-asserted-by":"crossref","first-page":"c570","DOI":"10.1136\/bmj.c570","volume":"340","author":"MT Leeuwen van","year":"2010","unstructured":"van Leeuwen, M. T., Webster, A. C., McCredie, M. R., et al. (2010). Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study. British Medical Journal, 340, c570.","journal-title":"British Medical Journal"},{"issue":"2","key":"9495_CR17","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0272-6386(00)70348-9","volume":"35","author":"AM Mattos de","year":"2000","unstructured":"de Mattos, A. M., Olyaei, A. J., & Bennett, W. M. (2000). Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future. American Journal of Kidney Disease, 35(2), 333\u2013346.","journal-title":"American Journal of Kidney Disease"},{"issue":"12","key":"9495_CR18","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1024\/0040-5930\/a000230","volume":"68","author":"F Stucker","year":"2011","unstructured":"Stucker, F., & Ackermann, D. (2011). Immunosuppressive drugs\u2014how they work, their side effects and interactions. Therapeutische Umschau, 68(12), 679\u2013686.","journal-title":"Therapeutische Umschau"},{"key":"9495_CR19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3389\/fimmu.2012.00345","volume":"3","author":"B Vaes","year":"2012","unstructured":"Vaes, B., Van\u2019t Hof, W., Deans, R., & Pinxteren, J. (2012). Application of multiStem((R)) allogeneic cells for immunomodulatory therapy: clinical progress and pre-clinical challenges in prophylaxis for graft versus host disease. Frontiers in Immunology, 3, 345.","journal-title":"Frontiers in Immunology"},{"issue":"2","key":"9495_CR20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.cellimm.2011.05.010","volume":"270","author":"G Raicevic","year":"2011","unstructured":"Raicevic, G., Najar, M., Stamatopoulos, B., et al. (2011). The source of human mesenchymal stromal cells influences their TLR profile as well as their functional properties. Cell Immunology, 270(2), 207\u2013216.","journal-title":"Cell Immunology"},{"issue":"12","key":"9495_CR21","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1089\/scd.2011.0031","volume":"20","author":"B Kronsteiner","year":"2011","unstructured":"Kronsteiner, B., Wolbank, S., Peterbauer, A., et al. (2011). Human mesenchymal stem cells from adipose tissue and amnion influence T-cells depending on stimulation method and presence of other immune cells. Stem Cells and Development, 20(12), 2115\u20132126.","journal-title":"Stem Cells and Development"},{"issue":"2","key":"9495_CR22","doi-asserted-by":"crossref","first-page":"e9016","DOI":"10.1371\/journal.pone.0009016","volume":"5","author":"SJ Prasanna","year":"2010","unstructured":"Prasanna, S. J., Gopalakrishnan, D., Shankar, S. R., & Vasandan, A. B. (2010). Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially. PLoS One, 5(2), e9016.","journal-title":"PLoS One"},{"issue":"4","key":"9495_CR23","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.trre.2008.05.002","volume":"22","author":"P Hematti","year":"2008","unstructured":"Hematti, P. (2008). Role of mesenchymal stromal cells in solid organ transplantation. Transplantation Reviews, 22(4), 262\u2013273.","journal-title":"Transplantation Reviews"},{"issue":"4","key":"9495_CR24","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1182\/blood-2010-06-287979","volume":"117","author":"N Haddad El","year":"2011","unstructured":"El Haddad, N., Heathcote, D., Moore, R., et al. (2011). Mesenchymal stem cells express serine protease inhibitor to evade the host immune response. Blood, 117(4), 1176\u20131183.","journal-title":"Blood"},{"issue":"9","key":"9495_CR25","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1182\/blood-2006-10-051060","volume":"109","author":"C Ries","year":"2007","unstructured":"Ries, C., Egea, V., Karow, M., et al. (2007). MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. Blood, 109(9), 4055\u20134063.","journal-title":"Blood"},{"issue":"9","key":"9495_CR26","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1182\/blood-2004-02-0526","volume":"104","author":"RF Wynn","year":"2004","unstructured":"Wynn, R. F., Hart, C. A., Corradi-Perini, C., et al. (2004). A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood, 104(9), 2643\u20132645.","journal-title":"Blood"},{"issue":"2","key":"9495_CR27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1517\/14712590903456011","volume":"10","author":"Z Zou","year":"2010","unstructured":"Zou, Z., Zhang, Y., Hao, L., et al. (2010). More insight into mesenchymal stem cells and their effects inside the body. Expert Opinion on Biological Therapy, 10(2), 215\u2013230.","journal-title":"Expert Opinion on Biological Therapy"},{"issue":"5","key":"9495_CR28","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/jcb.20886","volume":"98","author":"AI Caplan","year":"2006","unstructured":"Caplan, A. I., & Dennis, J. E. (2006). Mesenchymal stem cells as trophic mediators. Journal of Cellular Biochemistry, 98(5), 1076\u20131084.","journal-title":"Journal of Cellular Biochemistry"},{"issue":"1","key":"9495_CR29","doi-asserted-by":"crossref","first-page":"F31","DOI":"10.1152\/ajprenal.00007.2005","volume":"289","author":"F Togel","year":"2005","unstructured":"Togel, F., Hu, Z., Weiss, K., et al. (2005). Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. American Journal of Physiology - Renal Physiology, 289(1), F31\u2013F42.","journal-title":"American Journal of Physiology - Renal Physiology"},{"issue":"2","key":"9495_CR30","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/jcp.22081","volume":"223","author":"PJ Psaltis","year":"2010","unstructured":"Psaltis, P. J., Paton, S., See, F., et al. (2010). Enrichment for STRO\u20101 expression enhances the cardiovascular paracrine activity of human bone marrow\u2010derived mesenchymal cell populations. Journal of Cellular Physiology, 223(2), 530\u2013540.","journal-title":"Journal of Cellular Physiology"},{"issue":"6","key":"9495_CR31","first-page":"1035","volume":"14","author":"MB Herrera","year":"2004","unstructured":"Herrera, M. B., Bussolati, B., Bruno, S., et al. (2004). Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. International Journal of Molecular Medicine, 14(6), 1035\u20131041.","journal-title":"International Journal of Molecular Medicine"},{"issue":"2","key":"9495_CR32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.yjmcc.2006.07.002","volume":"42","author":"X Li","year":"2007","unstructured":"Li, X., Yu, X., Lin, Q., et al. (2007). Bone marrow mesenchymal stem cells differentiate into functional cardiac phenotypes by cardiac microenvironment. Journal of Molecular and Cellular Cardiology, 42(2), 295\u2013303.","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"9","key":"9495_CR33","doi-asserted-by":"crossref","first-page":"e76056","DOI":"10.1371\/journal.pone.0076056","volume":"8","author":"H Xie","year":"2013","unstructured":"Xie, H., Wang, Y., Zhang, H., et al. (2013). Role of injured pancreatic extract promotes bone marrow-derived mesenchymal stem cells efficiently differentiate into insulin-producing cells. PLoS One, 8(9), e76056.","journal-title":"PLoS One"},{"issue":"2","key":"9495_CR34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12015-008-9019-z","volume":"4","author":"YQ Xu","year":"2008","unstructured":"Xu, Y. Q., & Liu, Z. C. (2008). Therapeutic potential of adult bone marrow stem cells in liver disease and delivery approaches. Stem Cell Reviews, 4(2), 101\u2013112.","journal-title":"Stem Cell Reviews"},{"key":"9495_CR35","author":"PJ Tsai","year":"2013","unstructured":"Tsai, P. J., Wang, H. S., Lin, C. H., et al. (2013). Intraportal injection of insulin-producing cells generated from human bone marrow mesenchymal stem cells decreases blood glucose level in diabetic rats. Endocrine Research. doi: 10.3109\/07435800.2013.797432 .","journal-title":"Endocrine Research"},{"issue":"5","key":"9495_CR36","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.etp.2012.06.002","volume":"65","author":"R Moghadasali","year":"2013","unstructured":"Moghadasali, R., Mutsaers, H. A., Azarnia, M., et al. (2013). Mesenchymal stem cell-conditioned medium accelerates regeneration of human renal proximal tubule epithelial cells after gentamicin toxicity. Experimental and Toxicologic Pathology, 65(5), 595\u2013600.","journal-title":"Experimental and Toxicologic Pathology"},{"issue":"1","key":"9495_CR37","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1634\/stemcells.2007-0554","volume":"26","author":"Z Selmani","year":"2008","unstructured":"Selmani, Z., Naji, A., Zidi, I., et al. (2008). Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. Stem Cells, 26(1), 212\u2013222.","journal-title":"Stem Cells"},{"issue":"8","key":"9495_CR38","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/01.TP.0000082540.43730.80","volume":"76","author":"I Rasmusson","year":"2003","unstructured":"Rasmusson, I., Ringden, O., Sundberg, B., & Le Blanc, K. (2003). Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation, 76(8), 1208\u20131213.","journal-title":"Transplantation"},{"issue":"5","key":"9495_CR39","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/eji.200425405","volume":"35","author":"A Augello","year":"2005","unstructured":"Augello, A., Tasso, R., Negrini, S. M., et al. (2005). Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. European Journal of Immunology, 35(5), 1482\u20131490.","journal-title":"European Journal of Immunology"},{"issue":"1","key":"9495_CR40","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/01.tp.0000244572.24780.54","volume":"83","author":"R Ramasamy","year":"2007","unstructured":"Ramasamy, R., Fazekasova, H., Lam, E. W., et al. (2007). Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Transplantation, 83(1), 71\u201376.","journal-title":"Transplantation"},{"issue":"5","key":"9495_CR41","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/14653240701452057","volume":"9","author":"YJ Jung","year":"2007","unstructured":"Jung, Y. J., Ju, S. Y., Yoo, E. S., et al. (2007). MSC-DC interactions: MSC inhibit maturation and migration of BM-derived DC. Cytotherapy, 9(5), 451\u2013458.","journal-title":"Cytotherapy"},{"issue":"9419","key":"9495_CR42","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","volume":"363","author":"K Blanc Le","year":"2004","unstructured":"Le Blanc, K., Rasmusson, I., Sundberg, B., et al. (2004). Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet, 363(9419), 1439\u20131441.","journal-title":"Lancet"},{"issue":"7","key":"9495_CR43","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.bbmt.2008.03.012","volume":"15","author":"P Kebriaei","year":"2009","unstructured":"Kebriaei, P., Isola, L., Bahceci, E., et al. (2009). Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease. Biology of Blood and Marrow Transplantation, 15(7), 804\u2013811.","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"1","key":"9495_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-1797.2011.01501.x","volume":"17","author":"AF Wise","year":"2012","unstructured":"Wise, A. F., & Ricardo, S. D. (2012). Mesenchymal stem cells in kidney inflammation and repair. Nephrology, 17(1), 1\u201310.","journal-title":"Nephrology"},{"issue":"6","key":"9495_CR45","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1089\/dia.2009.0154","volume":"12","author":"B Longoni","year":"2010","unstructured":"Longoni, B., Szilagyi, E., Quaranta, P., et al. (2010). Mesenchymal stem cells prevent acute rejection and prolong graft function in pancreatic islet transplantation. Diabetes Technology and Therapeutics, 12(6), 435\u2013446.","journal-title":"Diabetes Technology and Therapeutics"},{"issue":"11","key":"9495_CR46","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1001\/jama.2012.316","volume":"307","author":"J Tan","year":"2012","unstructured":"Tan, J., Wu, W., Xu, X., et al. (2012). Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial. Journal of American Medical Association, 307(11), 1169\u20131177.","journal-title":"Journal of American Medical Association"},{"issue":"1","key":"9495_CR47","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0301-472X(01)00769-X","volume":"30","author":"A Bartholomew","year":"2002","unstructured":"Bartholomew, A., Sturgeon, C., Siatskas, M., et al. (2002). Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Experimental Hematology, 30(1), 42\u201348.","journal-title":"Experimental Hematology"},{"issue":"1","key":"9495_CR48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-3083.2003.01176.x","volume":"57","author":"K Blanc Le","year":"2003","unstructured":"Le Blanc, K., Tammik, L., Sundberg, B., Haynesworth, S. E., & Ringden, O. (2003). Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scandinavian Journal of Immunology, 57(1), 11\u201320.","journal-title":"Scandinavian Journal of Immunology"},{"issue":"11","key":"9495_CR49","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.tp.0000209919.90630.7b","volume":"81","author":"S Inoue","year":"2006","unstructured":"Inoue, S., Popp, F. C., Koehl, G. E., et al. (2006). Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model. Transplantation, 81(11), 1589\u20131595.","journal-title":"Transplantation"},{"issue":"8","key":"9495_CR50","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.2337\/db09-0317","volume":"58","author":"Y Ding","year":"2009","unstructured":"Ding, Y., Xu, D., Feng, G., et al. (2009). Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9. Diabetes, 58(8), 1797\u20131806.","journal-title":"Diabetes"},{"issue":"3","key":"9495_CR51","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.trim.2010.04.006","volume":"23","author":"KH Han","year":"2010","unstructured":"Han, K. H., Kang, H. G., Gil, H. J., et al. (2010). The immunosuppressive effect of embryonic stem cells and mesenchymal stem cells on both primary and secondary alloimmune responses. Transplant Immunology, 23(3), 141\u2013146.","journal-title":"Transplant Immunology"},{"issue":"6","key":"9495_CR52","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1182\/blood-2005-11-011650","volume":"108","author":"AJ Nauta","year":"2006","unstructured":"Nauta, A. J., Westerhuis, G., Kruisselbrink, A. B., et al. (2006). Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood, 108(6), 2114\u20132120.","journal-title":"Blood"},{"issue":"9","key":"9495_CR53","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1016\/j.transproceed.2006.10.002","volume":"38","author":"HP Zhou","year":"2006","unstructured":"Zhou, H. P., Yi, D. H., Yu, S. Q., et al. (2006). Administration of donor-derived mesenchymal stem cells can prolong the survival of rat cardiac allograft. Transplantation Proceedings, 38(9), 3046\u20133051.","journal-title":"Transplantation Proceedings"},{"issue":"11","key":"9495_CR54","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1002\/stem.217","volume":"27","author":"L Zangi","year":"2009","unstructured":"Zangi, L., Margalit, R., Reich-Zeliger, S., et al. (2009). Direct imaging of immune rejection and memory induction by allogeneic mesenchymal stromal cells. Stem Cells, 27(11), 2865\u20132874.","journal-title":"Stem Cells"},{"issue":"9","key":"9495_CR55","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1038\/mt.2013.147","volume":"21","author":"H Wu","year":"2013","unstructured":"Wu, H., Wen, D., & Mahato, R. I. (2013). Third-party mesenchymal stem cells improved human islet transplantation in a humanized diabetic mouse model. Molecular Therapy, 21(9), 1778\u20131786.","journal-title":"Molecular Therapy"},{"issue":"10","key":"9495_CR56","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood.V99.10.3838","volume":"99","author":"M Nicola Di","year":"2002","unstructured":"Di Nicola, M., Carlo-Stella, C., Magni, M., et al. (2002). Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood, 99(10), 3838\u20133843.","journal-title":"Blood"},{"issue":"4","key":"9495_CR57","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","volume":"105","author":"S Aggarwal","year":"2005","unstructured":"Aggarwal, S., & Pittenger, M. F. (2005). Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood, 105(4), 1815\u20131822.","journal-title":"Blood"},{"issue":"18","key":"9495_CR58","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1182\/blood-2010-12-324038","volume":"117","author":"D Mougiakakos","year":"2011","unstructured":"Mougiakakos, D., Jitschin, R., Johansson, C. C., et al. (2011). The impact of inflammatory licensing on heme oxygenase-1-mediated induction of regulatory T cells by human mesenchymal stem cells. Blood, 117(18), 4826\u20134835.","journal-title":"Blood"},{"issue":"20","key":"9495_CR59","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1089\/scd.2012.0676","volume":"22","author":"T Nguyen","year":"2013","unstructured":"Nguyen, T., Arthur, A., Hayball, J., & Gronthos, S. D. (2013). EphB and ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells. Stem Cells and Development, 22(20), 2751\u20132764.","journal-title":"Stem Cells and Development"},{"issue":"2","key":"9495_CR60","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3892\/ijo.2010.869","volume":"38","author":"M Sioud","year":"2011","unstructured":"Sioud, M., Mobergslien, A., Boudabous, A., & Floisand, Y. (2011). Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins. International Journal of Oncology, 38(2), 385\u2013390.","journal-title":"International Journal of Oncology"},{"issue":"2","key":"9495_CR61","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-3083.2010.02491.x","volume":"73","author":"M Sioud","year":"2011","unstructured":"Sioud, M. (2011). New insights into mesenchymal stromal cell-mediated T-cell suppression through galectins. Scandinavian Journal of Immunology, 73(2), 79\u201384.","journal-title":"Scandinavian Journal of Immunology"},{"issue":"4","key":"9495_CR62","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-3083.2010.02378.x","volume":"71","author":"M Sioud","year":"2010","unstructured":"Sioud, M., Mobergslien, A., Boudabous, A., & Floisand, Y. (2010). Evidence for the involvement of galectin-3 in mesenchymal stem cell suppression of allogeneic T-cell proliferation. Scandinavian Journal of Immunology, 71(4), 267\u2013274.","journal-title":"Scandinavian Journal of Immunology"},{"issue":"7","key":"9495_CR63","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1089\/scd.2009.0212","volume":"19","author":"Y Lepelletier","year":"2010","unstructured":"Lepelletier, Y., Lecourt, S., Renand, A., et al. (2010). Galectin-1 and semaphorin-3A are two soluble factors conferring T-cell immunosuppression to bone marrow mesenchymal stem cell. Stem Cells and Development, 19(7), 1075\u20131079.","journal-title":"Stem Cells and Development"},{"issue":"4","key":"9495_CR64","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1089\/scd.2010.0246","volume":"20","author":"N Wada","year":"2011","unstructured":"Wada, N., Bartold, P. M., & Gronthos, S. (2011). Human foreskin fibroblasts exert immunomodulatory properties by a different mechanism to bone marrow stromal\/stem cells. Stem Cells and Development, 20(4), 647\u2013659.","journal-title":"Stem Cells and Development"},{"issue":"3","key":"9495_CR65","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.0300-9475.2004.01483.x","volume":"60","author":"K Blanc Le","year":"2004","unstructured":"Le Blanc, K., Rasmusson, I., Gotherstrom, C., et al. (2004). Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes. Scandinavian Journal of Immunology, 60(3), 307\u2013315.","journal-title":"Scandinavian Journal of Immunology"},{"issue":"3","key":"9495_CR66","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/scrt216","volume":"4","author":"P Luz-Crawford","year":"2013","unstructured":"Luz-Crawford, P., Kurte, M., Bravo-Alegria, J., et al. (2013). Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells. Stem Cell Research and Therapy, 4(3), 65.","journal-title":"Stem Cell Research and Therapy"},{"issue":"8","key":"9495_CR67","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1089\/ten.2006.12.2263","volume":"12","author":"P Batten","year":"2006","unstructured":"Batten, P., Sarathchandra, P., Antoniw, J. W., et al. (2006). Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: relevance to tissue engineering human heart valves. Tissue Engineering, 12(8), 2263\u20132273.","journal-title":"Tissue Engineering"},{"issue":"8","key":"9495_CR68","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/cr.2008.80","volume":"18","author":"H Sheng","year":"2008","unstructured":"Sheng, H., Wang, Y., Jin, Y., et al. (2008). A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1. Cell Research, 18(8), 846\u2013857.","journal-title":"Cell Research"},{"issue":"9","key":"9495_CR69","doi-asserted-by":"crossref","first-page":"e45272","DOI":"10.1371\/journal.pone.0045272","volume":"7","author":"P Luz-Crawford","year":"2012","unstructured":"Luz-Crawford, P., Noel, D., Fernandez, X., et al. (2012). Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway. PLoS One, 7(9), e45272.","journal-title":"PLoS One"},{"issue":"1","key":"9495_CR70","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/scd.2009.0076","volume":"19","author":"Q Xue","year":"2010","unstructured":"Xue, Q., Luan, X. Y., Gu, Y. Z., et al. (2010). The negative co-signaling molecule b7-h4 is expressed by human bone marrow-derived mesenchymal stem cells and mediates its T-cell modulatory activity. Stem Cells and Development, 19(1), 27\u201338.","journal-title":"Stem Cells and Development"},{"issue":"1\u20132","key":"9495_CR71","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.imlet.2012.04.017","volume":"146","author":"M Najar","year":"2012","unstructured":"Najar, M., Raicevic, G., Jebbawi, F., et al. (2012). Characterization and functionality of the CD200-CD200R system during mesenchymal stromal cell interactions with T-lymphocytes. Immunology Letters, 146(1\u20132), 50\u201356.","journal-title":"Immunology Letters"},{"issue":"4","key":"9495_CR72","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/stem.7","volume":"27","author":"CA Opitz","year":"2009","unstructured":"Opitz, C. A., Litzenburger, U. M., Lutz, C., et al. (2009). Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via interferon-beta and protein kinase R. Stem Cells, 27(4), 909\u2013919.","journal-title":"Stem Cells"},{"issue":"5","key":"9495_CR73","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.stem.2012.03.007","volume":"10","author":"K Akiyama","year":"2012","unstructured":"Akiyama, K., Chen, C., Wang, D., et al. (2012). Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-\/FAS-mediated T cell apoptosis. Cell Stem Cell, 10(5), 544\u2013555.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"9495_CR74","doi-asserted-by":"crossref","first-page":"12","DOI":"10.14712\/18059694.2015.68","volume":"55","author":"D Holmannova","year":"2012","unstructured":"Holmannova, D., Kolackova, M., Kondelkova, K., et al. (2012). CD200\/CD200R paired potent inhibitory molecules regulating immune and inflammatory responses; Part I: CD200\/CD200R structure, activation, and function. Acta Medica (Hradec Kr\u00e1lov\u00e9), 55(1), 12\u201317.","journal-title":"Acta Medica (Hradec Kr\u00e1lov\u00e9)"},{"issue":"4","key":"9495_CR75","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.trim.2011.07.006","volume":"25","author":"RM Gorczynski","year":"2011","unstructured":"Gorczynski, R. M., Chen, Z., Khatri, I., & Yu, K. (2011). Graft-infiltrating cells expressing a CD200 transgene prolong allogeneic skin graft survival in association with local increases in Foxp3(+)Treg and mast cells. Transplant Immunology, 25(4), 187\u2013193.","journal-title":"Transplant Immunology"},{"issue":"3","key":"9495_CR76","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.4049\/jimmunol.0900200","volume":"183","author":"RM Gorczynski","year":"2009","unstructured":"Gorczynski, R. M., Chen, Z., He, W., et al. (2009). Expression of a CD200 transgene is necessary for induction but not maintenance of tolerance to cardiac and skin allografts. Journal of Immunology, 183(3), 1560\u20131568.","journal-title":"Journal of Immunology"},{"issue":"5","key":"9495_CR77","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1182\/blood-2004-07-2921","volume":"105","author":"S Beyth","year":"2005","unstructured":"Beyth, S., Borovsky, Z., Mevorach, D., et al. (2005). Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood, 105(5), 2214\u20132219.","journal-title":"Blood"},{"issue":"3","key":"9495_CR78","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1089\/154732804323099190","volume":"13","author":"W Zhang","year":"2004","unstructured":"Zhang, W., Ge, W., Li, C., et al. (2004). Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells and Development, 13(3), 263\u2013271.","journal-title":"Stem Cells and Development"},{"issue":"10","key":"9495_CR79","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1182\/blood-2004-02-0586","volume":"105","author":"XX Jiang","year":"2005","unstructured":"Jiang, X. X., Zhang, Y., Liu, B., et al. (2005). Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood, 105(10), 4120\u20134126.","journal-title":"Blood"},{"issue":"2","key":"9495_CR80","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1365-2249.2010.04178.x","volume":"161","author":"FR Li","year":"2010","unstructured":"Li, F. R., Wang, X. G., Deng, C. Y., et al. (2010). Immune modulation of co-transplantation mesenchymal stem cells with islet on T and dendritic cells. Clinical and Experimental Immunology, 161(2), 357\u2013363.","journal-title":"Clinical and Experimental Immunology"},{"issue":"10","key":"9495_CR81","doi-asserted-by":"crossref","first-page":"5065","DOI":"10.4049\/jimmunol.1202775","volume":"190","author":"HW Chen","year":"2013","unstructured":"Chen, H. W., Chen, H. Y., Wang, L. T., et al. (2013). Mesenchymal stem cells tune the development of monocyte-derived dendritic cells toward a myeloid-derived suppressive phenotype through growth-regulated oncogene Chemokines. Journal of Immunology, 190(10), 5065\u20135077.","journal-title":"Journal of Immunology"},{"issue":"1","key":"9495_CR82","doi-asserted-by":"crossref","first-page":"e55487","DOI":"10.1371\/journal.pone.0055487","volume":"8","author":"WH Liu","year":"2013","unstructured":"Liu, W. H., Liu, J. J., Wu, J., et al. (2013). Novel mechanism of inhibition of dendritic cells maturation by mesenchymal stem cells via interleukin-10 and the JAK1\/STAT3 signaling pathway. PLoS One, 8(1), e55487.","journal-title":"PLoS One"},{"issue":"6","key":"9495_CR83","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-3083.2008.02180.x","volume":"68","author":"Q Wang","year":"2008","unstructured":"Wang, Q., Sun, B., Wang, D., et al. (2008). Murine bone marrow mesenchymal stem cells cause mature dendritic cells to promote T-cell tolerance. Scandinavian Journal of Immunology, 68(6), 607\u2013615.","journal-title":"Scandinavian Journal of Immunology"},{"issue":"12","key":"9495_CR84","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1097\/TP.0b013e3181fed001","volume":"90","author":"W Ge","year":"2010","unstructured":"Ge, W., Jiang, J., Arp, J., et al. (2010). Regulatory T-cell generation and kidney allograft tolerance induced by mesenchymal stem cells associated with indoleamine 2,3-dioxygenase expression. Transplantation, 90(12), 1312\u20131320.","journal-title":"Transplantation"},{"key":"9495_CR85","doi-asserted-by":"crossref","unstructured":"Spaggiari, G. M., & Moretta, L. (2012). Interactions between mesenchymal stem cells and dendritic cells. Advances in Biochemical Engineering\/Biotechnology. doi: 10.1007\/10_2012_154 .","DOI":"10.1007\/10_2012_154"},{"issue":"1","key":"9495_CR86","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/14653249.2011.594792","volume":"14","author":"B Rocher Du","year":"2012","unstructured":"Du Rocher, B., Mencalha, A. L., Gomes, B. E., & Abdelhay, E. (2012). Mesenchymal stromal cells impair the differentiation of CD14(++) CD16(-) CD64(+) classical monocytes into CD14(++) CD16(+) CD64(++) activate monocytes. Cytotherapy, 14(1), 12\u201325.","journal-title":"Cytotherapy"},{"issue":"9","key":"9495_CR87","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1089\/ten.tea.2009.0731","volume":"16","author":"HY Lai","year":"2010","unstructured":"Lai, H. Y., Yang, M. J., Wen, K. C., et al. (2010). Mesenchymal stem cells negatively regulate dendritic lineage commitment of umbilical-cord-blood-derived hematopoietic stem cells: an unappreciated mechanism as immunomodulators. Tissue Engineering Part A, 16(9), 2987\u20132997.","journal-title":"Tissue Engineering Part A"},{"issue":"26","key":"9495_CR88","doi-asserted-by":"crossref","first-page":"6576","DOI":"10.1182\/blood-2009-02-203943","volume":"113","author":"GM Spaggiari","year":"2009","unstructured":"Spaggiari, G. M., Abdelrazik, H., Becchetti, F., & Moretta, L. (2009). MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. Blood, 113(26), 6576\u20136583.","journal-title":"Blood"},{"issue":"8","key":"9495_CR89","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1634\/stemcells.2006-0548","volume":"25","author":"F Djouad","year":"2007","unstructured":"Djouad, F., Charbonnier, L. M., Bouffi, C., et al. (2007). Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells, 25(8), 2025\u20132032.","journal-title":"Stem Cells"},{"issue":"5","key":"9495_CR90","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1089\/scd.2007.0065","volume":"16","author":"L Chen","year":"2007","unstructured":"Chen, L., Zhang, W., Yue, H., et al. (2007). Effects of human mesenchymal stem cells on the differentiation of dendritic cells from CD34+ cells. Stem Cells and Development, 16(5), 719\u2013731.","journal-title":"Stem Cells and Development"},{"issue":"9","key":"9495_CR91","doi-asserted-by":"crossref","first-page":"5102","DOI":"10.4049\/jimmunol.1001332","volume":"185","author":"A Aldinucci","year":"2010","unstructured":"Aldinucci, A., Rizzetto, L., Pieri, L., et al. (2010). Inhibition of immune synapse by altered dendritic cell actin distribution: a new pathway of mesenchymal stem cell immune regulation. Journal of Immunology, 185(9), 5102\u20135110.","journal-title":"Journal of Immunology"},{"issue":"1","key":"9495_CR92","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.imlet.2007.10.002","volume":"115","author":"K English","year":"2008","unstructured":"English, K., Barry, F. P., & Mahon, B. P. (2008). Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation. Immunology Letters, 115(1), 50\u201358.","journal-title":"Immunology Letters"},{"issue":"42","key":"9495_CR93","doi-asserted-by":"crossref","first-page":"17384","DOI":"10.1073\/pnas.1103650108","volume":"108","author":"S Chiesa","year":"2011","unstructured":"Chiesa, S., Morbelli, S., Morando, S., et al. (2011). Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells. Proceedings of the National Academy of Sciences of the United States of America, 108(42), 17384\u201317389.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"10","key":"9495_CR94","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1634\/stemcells.2008-0146","volume":"26","author":"H Li","year":"2008","unstructured":"Li, H., Guo, Z., Jiang, X., et al. (2008). Mesenchymal stem cells alter migratory property of T and dendritic cells to delay the development of murine lethal acute graft-versus-host disease. Stem Cells, 26(10), 2531\u20132541.","journal-title":"Stem Cells"},{"issue":"2","key":"9495_CR95","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/08820139.2011.607877","volume":"41","author":"ZG Zhao","year":"2012","unstructured":"Zhao, Z. G., Xu, W., Sun, L., et al. (2012). Immunomodulatory function of regulatory dendritic cells induced by mesenchymal stem cells. Immunological Investigations, 41(2), 183\u2013198.","journal-title":"Immunological Investigations"},{"issue":"1","key":"9495_CR96","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1182\/blood-2008-04-154138","volume":"113","author":"B Zhang","year":"2009","unstructured":"Zhang, B., Liu, R., Shi, D., et al. (2009). Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2-dependent regulatory dendritic cell population. Blood, 113(1), 46\u201357.","journal-title":"Blood"},{"issue":"6","key":"9495_CR97","first-page":"568","volume":"28","author":"JY Weng","year":"2012","unstructured":"Weng, J. Y., Huang, X., Lai, P. L., et al. (2012). A method for induction of mouse CD8alpha(+);CD11b(+);jagged2(high);regulatory dendritic cells with mesenchymal stem cells in vitro. Chinese Journal of Cellular and Molecular Immunology, 28(6), 568\u2013571.","journal-title":"Chinese Journal of Cellular and Molecular Immunology"},{"issue":"10","key":"9495_CR98","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.2337\/db10-0136","volume":"59","author":"DM Berman","year":"2010","unstructured":"Berman, D. M., Willman, M. A., Han, D., et al. (2010). Mesenchymal stem cells enhance allogeneic islet engraftment in nonhuman primates. Diabetes, 59(10), 2558\u20132568.","journal-title":"Diabetes"},{"issue":"10","key":"9495_CR99","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/archneurol.2010.248","volume":"67","author":"D Karussis","year":"2010","unstructured":"Karussis, D., Karageorgiou, C., Vaknin-Dembinsky, A., et al. (2010). Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Archives of Neurology, 67(10), 1187\u20131194.","journal-title":"Archives of Neurology"},{"issue":"1","key":"9495_CR100","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2249.2009.03874.x","volume":"156","author":"K English","year":"2009","unstructured":"English, K., Ryan, J. M., Tobin, L., et al. (2009). Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells. Clinical and Experimental Immunology, 156(1), 149\u2013160.","journal-title":"Clinical and Experimental Immunology"},{"issue":"5","key":"9495_CR101","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.4049\/jimmunol.1202996","volume":"190","author":"WT Hsu","year":"2013","unstructured":"Hsu, W. T., Lin, C. H., Chiang, B. L., et al. (2013). Prostaglandin E2 potentiates mesenchymal stem cell-induced IL-10+IFN-gamma+CD4+ regulatory T cells to control transplant arteriosclerosis. Journal of Immunology, 190(5), 2372\u20132380.","journal-title":"Journal of Immunology"},{"issue":"10","key":"9495_CR102","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.4049\/jimmunol.0903143","volume":"184","author":"SA Patel","year":"2010","unstructured":"Patel, S. A., Meyer, J. R., Greco, S. J., et al. (2010). Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta. Journal of Immunology, 184(10), 5885\u20135894.","journal-title":"Journal of Immunology"},{"issue":"7","key":"9495_CR103","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.exphem.2005.05.006","volume":"33","author":"A Bacigalupo","year":"2005","unstructured":"Bacigalupo, A., Valle, M., Podest\u00e0, M., et al. (2005). T-cell suppression mediated by mesenchymal stem cells is deficient in patients with severe aplastic anemia. Experimental Hematology, 33(7), 819\u2013827.","journal-title":"Experimental Hematology"},{"issue":"6","key":"9495_CR104","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jbspin.2003.08.001","volume":"70","author":"C Jorgensen","year":"2003","unstructured":"Jorgensen, C., Djouad, F., Fritz, V., et al. (2003). Mesenchymal stem cells and rheumatoid arthritis. Joint, Bone, Spine, 70(6), 483\u2013485.","journal-title":"Joint, Bone, Spine"},{"issue":"6","key":"9495_CR105","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3109\/14653249.2012.663483","volume":"14","author":"K Neef","year":"2012","unstructured":"Neef, K., Choi, Y. H., Weichel, A., et al. (2012). The influence of cardiovascular risk factors on bone marrow mesenchymal stromal cell fitness. Cytotherapy, 14(6), 670\u2013678.","journal-title":"Cytotherapy"},{"issue":"3","key":"9495_CR106","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/rheumatology\/kel267","volume":"46","author":"C Bocelli-Tyndall","year":"2007","unstructured":"Bocelli-Tyndall, C., Bracci, L., Spagnoli, G., et al. (2007). Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro. Rheumatology, 46(3), 403\u2013408.","journal-title":"Rheumatology"},{"issue":"6","key":"9495_CR107","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3109\/14653240903051558","volume":"11","author":"JA Perez-Simon","year":"2009","unstructured":"Perez-Simon, J. A., Tabera, S., Sarasquete, M. E., et al. (2009). Mesenchymal stem cells are functionally abnormal in patients with immune thrombocytopenic purpura. Cytotherapy, 11(6), 698\u2013705.","journal-title":"Cytotherapy"},{"issue":"4","key":"9495_CR108","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1189\/jlb.0307140","volume":"82","author":"I Rasmusson","year":"2007","unstructured":"Rasmusson, I., Uhlin, M., Le Blanc, K., & Levitsky, V. (2007). Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes. Journal of Leukocyte Biology, 82(4), 887\u2013893.","journal-title":"Journal of Leukocyte Biology"},{"key":"9495_CR109","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-9255-2-8","volume":"2","author":"JM Ryan","year":"2005","unstructured":"Ryan, J. M., Barry, F. P., Murphy, J. M., & Mahon, B. P. (2005). Mesenchymal stem cells avoid allogeneic rejection. Journal of Inflammation, 2, 8.","journal-title":"Journal of Inflammation"},{"issue":"5","key":"9495_CR110","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.molmed.2010.02.005","volume":"16","author":"J Ankrum","year":"2010","unstructured":"Ankrum, J., & Karp, J. M. (2010). Mesenchymal stem cell therapy: two steps forward, one step back. Trends in Molecular Medicine, 16(5), 203\u2013209.","journal-title":"Trends in Molecular Medicine"},{"issue":"4","key":"9495_CR111","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.bbmt.2006.12.447","volume":"13","author":"AT Badillo","year":"2007","unstructured":"Badillo, A. T., Beggs, K. J., Javazon, E. H., Tebbets, J. C., & Flake, A. W. (2007). Murine bone marrow stromal progenitor cells elicit an in vivo cellular and humoral alloimmune response. Biology of Blood and Marrow Transplantation, 13(4), 412\u2013422.","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"10","key":"9495_CR112","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1038\/mt.2009.157","volume":"17","author":"M Rafei","year":"2009","unstructured":"Rafei, M., Birman, E., Forner, K., & Galipeau, J. (2009). Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitis. Molecular Therapy, 17(10), 1799\u20131803.","journal-title":"Molecular Therapy"},{"issue":"9","key":"9495_CR113","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1111\/j.1582-4934.2011.01509.x","volume":"16","author":"S Schu","year":"2012","unstructured":"Schu, S., Nosov, M., O\u2019Flynn, L., et al. (2012). Immunogenicity of allogeneic mesenchymal stem cells. Journal of Cellular and Molecular Medicine, 16(9), 2094\u20132103.","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"12","key":"9495_CR114","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1089\/hum.2010.156","volume":"21","author":"MD Griffin","year":"2010","unstructured":"Griffin, M. D., Ritter, T., & Mahon, B. P. (2010). Immunological aspects of allogeneic mesenchymal stem cell therapies. Human Gene Therapy, 21(12), 1641\u20131655.","journal-title":"Human Gene Therapy"},{"issue":"1","key":"9495_CR115","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/icb.2012.67","volume":"91","author":"MD Griffin","year":"2013","unstructured":"Griffin, M. D., Ryan, A. E., Alagesan, S., et al. (2013). Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far? Immunology and Cell Biology, 91(1), 40\u201351.","journal-title":"Immunology and Cell Biology"},{"issue":"3","key":"9495_CR116","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00403-007-0827-9","volume":"300","author":"P Sbano","year":"2008","unstructured":"Sbano, P., Cuccia, A., Mazzanti, B., et al. (2008). Use of donor bone marrow mesenchymal stem cells for treatment of skin allograft rejection in a preclinical rat model. Archives of Dermatological Research, 300(3), 115\u2013124.","journal-title":"Archives of Dermatological Research"},{"issue":"6","key":"9495_CR117","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.4049\/jimmunol.181.6.3933","volume":"181","author":"F Casiraghi","year":"2008","unstructured":"Casiraghi, F., Azzollini, N., Cassis, P., et al. (2008). Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells. Journal of Immunology, 181(6), 3933\u20133946.","journal-title":"Journal of Immunology"},{"issue":"1\u20132","key":"9495_CR118","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.trim.2008.08.004","volume":"20","author":"FC Popp","year":"2008","unstructured":"Popp, F. C., Eggenhofer, E., Renner, P., et al. (2008). Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate. Transplant Immunology, 20(1\u20132), 55\u201360.","journal-title":"Transplant Immunology"},{"issue":"3","key":"9495_CR119","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.trim.2010.12.002","volume":"24","author":"E Eggenhofer","year":"2011","unstructured":"Eggenhofer, E., Steinmann, J. F., Renner, P., et al. (2011). Mesenchymal stem cells together with mycophenolate mofetil inhibit antigen presenting cell and T cell infiltration into allogeneic heart grafts. Transplant Immunology, 24(3), 157\u2013163.","journal-title":"Transplant Immunology"},{"issue":"2\u20133","key":"9495_CR120","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.trim.2011.06.002","volume":"25","author":"E Eggenhofer","year":"2011","unstructured":"Eggenhofer, E., Renner, P., Soeder, Y., et al. (2011). Features of synergism between mesenchymal stem cells and immunosuppressive drugs in a murine heart transplantation model. Transplant Immunology, 25(2\u20133), 141\u2013147.","journal-title":"Transplant Immunology"},{"key":"9495_CR121","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.exer.2012.06.008","volume":"102","author":"Z Jia","year":"2012","unstructured":"Jia, Z., Jiao, C., Zhao, S., et al. (2012). Immunomodulatory effects of mesenchymal stem cells in a rat corneal allograft rejection model. Experimental Eye Research, 102, 44\u201349.","journal-title":"Experimental Eye Research"},{"key":"9495_CR122","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3389\/fimmu.2012.00202","volume":"3","author":"M Seifert","year":"2012","unstructured":"Seifert, M., Stolk, M., Polenz, D., & Volk, H. D. (2012). Detrimental effects of rat mesenchymal stromal cell pre-treatment in a model of acute kidney rejection. Frontiers in Immunology, 3, 202.","journal-title":"Frontiers in Immunology"},{"issue":"8","key":"9495_CR123","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/j.1600-6143.2009.02721.x","volume":"9","author":"W Ge","year":"2009","unstructured":"Ge, W., Jiang, J., Baroja, M. L., et al. (2009). Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance. American Journal of Transplantation, 9(8), 1760\u20131772.","journal-title":"American Journal of Transplantation"},{"issue":"2","key":"9495_CR124","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaut.2009.01.003","volume":"32","author":"MG Solari","year":"2009","unstructured":"Solari, M. G., Srinivasan, S., Boumaza, I., et al. (2009). Marginal mass islet transplantation with autologous mesenchymal stem cells promotes long-term islet allograft survival and sustained normoglycemia. Journal of Autoimmunity, 32(2), 116\u2013124.","journal-title":"Journal of Autoimmunity"},{"issue":"9","key":"9495_CR125","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1182\/blood-2002-07-2104","volume":"101","author":"M Krampera","year":"2003","unstructured":"Krampera, M., Glennie, S., Dyson, J., et al. (2003). Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood, 101(9), 3722\u20133729.","journal-title":"Blood"},{"issue":"11","key":"9495_CR126","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.exphem.2008.06.008","volume":"36","author":"WK Chan","year":"2008","unstructured":"Chan, W. K., Lau, A. S., Li, J. C., et al. (2008). MHC expression kinetics and immunogenicity of mesenchymal stromal cells after short-term IFN-gamma challenge. Experimental Hematology, 36(11), 1545\u20131555.","journal-title":"Experimental Hematology"},{"issue":"6","key":"9495_CR127","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/eji.200738129","volume":"38","author":"D Polchert","year":"2008","unstructured":"Polchert, D., Sobinsky, J., Douglas, G., et al. (2008). IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease. European Journal of Immunology, 38(6), 1745\u20131755.","journal-title":"European Journal of Immunology"},{"issue":"2","key":"9495_CR128","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1634\/stemcells.2005-0008","volume":"24","author":"M Krampera","year":"2006","unstructured":"Krampera, M., Cosmi, L., Angeli, R., et al. (2006). Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells, 24(2), 386\u2013398.","journal-title":"Stem Cells"},{"issue":"2","key":"9495_CR129","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.stem.2007.11.014","volume":"2","author":"G Ren","year":"2008","unstructured":"Ren, G., Zhang, L., Zhao, X., et al. (2008). Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell, 2(2), 141\u2013150.","journal-title":"Cell Stem Cell"},{"issue":"2","key":"9495_CR130","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/cei.12056","volume":"172","author":"LM Tobin","year":"2013","unstructured":"Tobin, L. M., Healy, M. E., English, K., & Mahon, B. P. (2013). Human mesenchymal stem cells suppress donor CD4(+) T cell proliferation and reduce pathology in a humanized mouse model of acute graft-versus-host disease. Clinical and Experimental Immunology, 172(2), 333\u2013348.","journal-title":"Clinical and Experimental Immunology"},{"issue":"19","key":"9495_CR131","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1089\/scd.2013.0079","volume":"22","author":"T Erkers","year":"2013","unstructured":"Erkers, T., Nava, S., Yosef, J., Ringden, O., & Kaipe, H. (2013). Decidual stromal cells promote regulatory T cells and suppress alloreactivity in a cell contact-dependent manner. Stem Cells and Development, 22(19), 2596\u20132605.","journal-title":"Stem Cells and Development"},{"issue":"10","key":"9495_CR132","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/stem.698","volume":"29","author":"M Duijvestein","year":"2011","unstructured":"Duijvestein, M., Wildenberg, M. E., Welling, M. M., et al. (2011). Pretreatment with interferon-gamma enhances the therapeutic activity of mesenchymal stromal cells in animal models of colitis. Stem Cells, 29(10), 1549\u20131558.","journal-title":"Stem Cells"},{"issue":"12","key":"9495_CR133","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1182\/blood-2003-11-3909","volume":"103","author":"R Meisel","year":"2004","unstructured":"Meisel, R., Zibert, A., Laryea, M., et al. (2004). Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood, 103(12), 4619\u20134621.","journal-title":"Blood"},{"issue":"5380","key":"9495_CR134","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1126\/science.281.5380.1191","volume":"281","author":"DH Munn","year":"1998","unstructured":"Munn, D. H., Zhou, M., Attwood, J. T., et al. (1998). Prevention of allogeneic fetal rejection by tryptophan catabolism. Science, 281(5380), 1191\u20131193.","journal-title":"Science"},{"issue":"2","key":"9495_CR135","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1365-2249.2007.03422.x","volume":"149","author":"JM Ryan","year":"2007","unstructured":"Ryan, J. M., Barry, F., Murphy, J. M., & Mahon, B. P. (2007). Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clinical and Experimental Immunology, 149(2), 353\u2013363.","journal-title":"Clinical and Experimental Immunology"},{"issue":"1","key":"9495_CR136","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/mt.2011.189","volume":"20","author":"M Francois","year":"2012","unstructured":"Francois, M., Romieu-Mourez, R., Li, M., & Galipeau, J. (2012). Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation. Molecular Therapy, 20(1), 187\u2013195.","journal-title":"Molecular Therapy"},{"issue":"3","key":"9495_CR137","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/jcp.21710","volume":"219","author":"N Wada","year":"2009","unstructured":"Wada, N., Menicanin, D., Shi, S., Bartold, P. M., & Gronthos, S. (2009). Immunomodulatory properties of human periodontal ligament stem cells. Journal of Cellular Physiology, 219(3), 667\u2013676.","journal-title":"Journal of Cellular Physiology"},{"issue":"7","key":"9495_CR138","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","volume":"192","author":"GJ Freeman","year":"2000","unstructured":"Freeman, G. J., Long, A. J., Iwai, Y., et al. (2000). Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. The Journal of Experimental Medicine, 192(7), 1027\u20131034.","journal-title":"The Journal of Experimental Medicine"},{"issue":"2","key":"9495_CR139","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.imlet.2007.04.001","volume":"110","author":"K English","year":"2007","unstructured":"English, K., Barry, F. P., Field-Corbett, C. P., & Mahon, B. P. (2007). IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells. Immunology Letters, 110(2), 91\u2013100.","journal-title":"Immunology Letters"},{"issue":"3","key":"9495_CR140","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/TP.0b013e31823ffd39","volume":"93","author":"HS Chou","year":"2012","unstructured":"Chou, H. S., Hsieh, C. C., Charles, R., et al. (2012). Myeloid-derived suppressor cells protect islet transplants by B7-H1 mediated enhancement of T regulatory cells. Transplantation, 93(3), 272\u2013282.","journal-title":"Transplantation"},{"issue":"13","key":"9495_CR141","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1084\/jem.20090847","volume":"206","author":"LM Francisco","year":"2009","unstructured":"Francisco, L. M., Salinas, V. H., Brown, K. E., et al. (2009). PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. The Journal of Experimental Medicine, 206(13), 3015\u20133029.","journal-title":"The Journal of Experimental Medicine"},{"issue":"6","key":"9495_CR142","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.4049\/jimmunol.173.6.3748","volume":"173","author":"F Fallarino","year":"2004","unstructured":"Fallarino, F., Asselin-Paturel, C., Vacca, C., et al. (2004). Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement. Journal of Immunology, 173(6), 3748\u20133754.","journal-title":"Journal of Immunology"},{"key":"9495_CR143","doi-asserted-by":"crossref","unstructured":"Lee, S., Szilagyi, E., Chen, L., et al. (2012). Activated mesenchymal stem cells increase wound tensile strength in aged mouse model via macrophages. The Journal of Surgical Research, 181(1), 20\u201324.","DOI":"10.1016\/j.jss.2012.05.040"},{"issue":"10","key":"9495_CR144","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1182\/blood-2004-11-4349","volume":"105","author":"A Kortesidis","year":"2005","unstructured":"Kortesidis, A., Zannettino, A., Isenmann, S., et al. (2005). Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood, 105(10), 3793\u20133801.","journal-title":"Blood"},{"issue":"13","key":"9495_CR145","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1182\/blood-2005-03-1004","volume":"106","author":"N Eliopoulos","year":"2005","unstructured":"Eliopoulos, N., Stagg, J., Lejeune, L., Pommey, S., & Galipeau, J. (2005). Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice. Blood, 106(13), 4057\u20134065.","journal-title":"Blood"},{"issue":"6","key":"9495_CR146","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1182\/blood-2007-04-083162","volume":"110","author":"F Gieseke","year":"2007","unstructured":"Gieseke, F., Schutt, B., Viebahn, S., et al. (2007). Human multipotent mesenchymal stromal cells inhibit proliferation of PBMCs independently of IFNgammaR1 signaling and IDO expression. Blood, 110(6), 2197\u20132200.","journal-title":"Blood"},{"issue":"7","key":"9495_CR147","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.4049\/jimmunol.171.7.3426","volume":"171","author":"JA Potian","year":"2003","unstructured":"Potian, J. A., Aviv, H., Ponzio, N. M., Harrison, J. S., & Rameshwar, P. (2003). Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. Journal of Immunology, 171(7), 3426\u20133434.","journal-title":"Journal of Immunology"},{"issue":"3","key":"9495_CR148","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3109\/14653249.2010.523077","volume":"13","author":"C Gotherstrom","year":"2011","unstructured":"Gotherstrom, C., Lundqvist, A., Duprez, I. R., et al. (2011). Fetal and adult multipotent mesenchymal stromal cells are killed by different pathways. Cytotherapy, 13(3), 269\u2013278.","journal-title":"Cytotherapy"},{"issue":"2","key":"9495_CR149","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/mt.2008.270","volume":"17","author":"PM Campeau","year":"2009","unstructured":"Campeau, P. M., Rafei, M., Francois, M., et al. (2009). Mesenchymal stromal cells engineered to express erythropoietin induce anti-erythropoietin antibodies and anemia in allorecipients. Molecular Therapy, 17(2), 369\u2013372.","journal-title":"Molecular Therapy"},{"issue":"6","key":"9495_CR150","first-page":"657","volume":"25","author":"GQ Wang","year":"2006","unstructured":"Wang, G. Q., Xu, J. R., Wang, R., et al. (2006). Inhibitory effect of mesenchymal stem cells carrying murine beta defensin 2 on malignant ascites in mice. Chinese Journal of Cancer, 25(6), 657\u2013662.","journal-title":"Chinese Journal of Cancer"},{"key":"9495_CR151","author":"G Ren","year":"2013","unstructured":"Ren, G., Liu, Y., Zhao, X., et al. (2013). Tumor resident mesenchymal stromal cells endow naive stromal cells with tumor-promoting properties. Oncogene. doi: 10.1038\/onc.2013.387 .","journal-title":"Oncogene"},{"issue":"6","key":"9495_CR152","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000337296","volume":"79","author":"K Nishimura","year":"2012","unstructured":"Nishimura, K., Semba, S., Aoyagi, K., Sasaki, H., & Yokozaki, H. (2012). Mesenchymal stem cells provide an advantageous tumor microenvironment for the restoration of cancer stem cells. Pathobiology, 79(6), 290\u2013306.","journal-title":"Pathobiology"},{"issue":"13","key":"9495_CR153","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1158\/0008-5472.CAN-08-4630","volume":"69","author":"GV Rosland","year":"2009","unstructured":"Rosland, G. V., Svendsen, A., Torsvik, A., et al. (2009). Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Research, 69(13), 5331\u20135339.","journal-title":"Cancer Research"},{"issue":"4","key":"9495_CR154","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1182\/blood-2006-12-063412","volume":"110","author":"M Breitbach","year":"2007","unstructured":"Breitbach, M., Bostani, T., Roell, W., et al. (2007). Potential risks of bone marrow cell transplantation into infarcted hearts. Blood, 110(4), 1362\u20131369.","journal-title":"Blood"},{"issue":"6","key":"9495_CR155","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1681\/ASN.2007010044","volume":"18","author":"U Kunter","year":"2007","unstructured":"Kunter, U., Rong, S., Boor, P., et al. (2007). Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. Journal of the American Society of Nephrology, 18(6), 1754\u20131764.","journal-title":"Journal of the American Society of Nephrology"},{"issue":"10","key":"9495_CR156","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.exphem.2008.04.022","volume":"36","author":"TB Prigozhina","year":"2008","unstructured":"Prigozhina, T. B., Khitrin, S., Elkin, G., et al. (2008). Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation. Experimental Hematology, 36(10), 1370\u20131376.","journal-title":"Experimental Hematology"},{"issue":"8","key":"9495_CR157","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.biocel.2012.04.015","volume":"44","author":"J Du","year":"2012","unstructured":"Du, J., Zhou, L., Chen, X., et al. (2012). IFN-gamma-primed human bone marrow mesenchymal stem cells induce tumor cell apoptosis in vitro via tumor necrosis factor-related apoptosis-inducing ligand. The International Journal of Biochemistry Cell Biology, 44(8), 1305\u20131314.","journal-title":"The International Journal of Biochemistry Cell Biology"},{"issue":"5","key":"9495_CR158","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1172\/JCI31178","volume":"117","author":"DH Munn","year":"2007","unstructured":"Munn, D. H., & Mellor, A. L. (2007). Indoleamine 2,3-dioxygenase and tumor-induced tolerance. The Journal of Clinical Investigation, 117(5), 1147\u20131154.","journal-title":"The Journal of Clinical Investigation"},{"issue":"8","key":"9495_CR159","first-page":"733","volume":"48","author":"XM Zhang","year":"2012","unstructured":"Zhang, X. M., Jiao, C. N., Jia, Z., et al. (2012). Investigation of the role of mesenchymal stem cells on keratoplasty rejection. Chinese Journal of Ophthalmology, 48(8), 733\u2013738.","journal-title":"Chinese Journal of Ophthalmology"},{"issue":"2","key":"9495_CR160","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2215\/CJN.04950610","volume":"6","author":"N Perico","year":"2011","unstructured":"Perico, N., Casiraghi, F., Introna, M., et al. (2011). Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility. Clinical Journal of the American Society of Nephrology, 6(2), 412\u2013422.","journal-title":"Clinical Journal of the American Society of Nephrology"},{"issue":"1","key":"9495_CR161","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/TP.0b013e3182754c53","volume":"95","author":"Y Peng","year":"2013","unstructured":"Peng, Y., Ke, M., Xu, L., et al. (2013). Donor-derived mesenchymal stem cells combined with low-dose tacrolimus prevent acute rejection after renal transplantation: a clinical pilot study. Transplantation, 95(1), 161\u2013168.","journal-title":"Transplantation"},{"issue":"2","key":"9495_CR162","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5966\/sctm.2012-0114","volume":"2","author":"ME Reinders","year":"2013","unstructured":"Reinders, M. E., de Fijter, J. W., Roelofs, H., et al. (2013). Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study. Stem Cells Translational Medicine, 2(2), 107\u2013111.","journal-title":"Stem Cells Translational Medicine"},{"issue":"9","key":"9495_CR163","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/tri.12132","volume":"26","author":"N Perico","year":"2013","unstructured":"Perico, N., Casiraghi, F., Gotti, E., et al. (2013). Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation. Transplant International, 26(9), 867\u2013878.","journal-title":"Transplant International"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-014-9495-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12015-014-9495-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-014-9495-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T03:11:25Z","timestamp":1716520285000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12015-014-9495-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,9]]},"references-count":163,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["9495"],"URL":"https:\/\/doi.org\/10.1007\/s12015-014-9495-2","relation":{},"ISSN":["1550-8943","1558-6804"],"issn-type":[{"value":"1550-8943","type":"print"},{"value":"1558-6804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,9]]}}}